Monitoring of the pharmacological treatment availability in patients with multiple sclerosis in the Greater Poland population

Monitoring of the pharmacological treatment availability in patients with multiple sclerosis in the Greater Poland population

Introduction There is no clear explanation for the availability of multiple sclerosis (MS) pharmacological treatment for patients in Greater Poland and it can be assumed that the same reason is common in most of the developed countries in the United Europe. As an autoimmune disease MS can overlap wi...

Full description

Bibliographic Details
Main Authors: Przemyslaw Daroszewski, Katarzyna Kaczmarek, Juliusz Huber
Format: Article
Language:English
Published: Termedia Publishing House 2024-01-01
Series:Rheumatology
Subjects:
pharmacological treatment
multiple sclerosis
availability problems
Online Access:https://reu.termedia.pl/Monitoring-of-the-pharmacological-treatment-availability-in-patients-with-multiple,177143,0,2.html

Internet

https://reu.termedia.pl/Monitoring-of-the-pharmacological-treatment-availability-in-patients-with-multiple,177143,0,2.html

Similar Items